Results 261 to 270 of about 134,525 (341)
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli +8 more
wiley +1 more source
Hypoxia exposure activates HIF‐2α, which binds to the Camk4 promoter to enhance RANKL‐mediated osteoclast differentiation, leading to aggravated alveolar bone resorption in periapical periodontitis. ABSTRACT Periapical periodontitis is one of the most common inflammatory bone destructive diseases. Epidemiological evidence suggests that hypoxia exposure,
Kang Gao +11 more
wiley +1 more source
An analysis of the functions of the Epstein-Barr virus latent proteins, LMP1 and EBNA3
Pamela Morgan
openalex +1 more source
Regulation of Human T-Lymphotropic Virus Type I Latency and Reactivation by HBZ and Rex
Subha Philip +4 more
openalex +2 more sources
Clinical‐grade HLA‐homozygous iPSC‐derived neural precursor cells restore motor function, rebuild striatal circuitry and reduce neuroinflammation in QA‐lesioned rats. These findings demonstrate robust neuronal replacement and microenvironment modulation, supporting their potential as a regenerative therapy for Huntington's disease.
Hyeonjoong Jeon +6 more
wiley +1 more source
Epstein-Barr virus-associated lymphoma: current understanding and treatment strategies. [PDF]
Ju HY.
europepmc +1 more source
ABSTRACT Aim To describe the first Italian experience with teplizumab administered under a compassionate use programme for adults with Stage 2 type 1 diabetes (T1D), and to evaluate its feasibility, safety and early metabolic outcomes in a real‐life clinical setting outside formal clinical trials.
V. Guarnotta +6 more
wiley +1 more source
Association of GLP‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
ABSTRACT Aims To evaluate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) initiation and the risk of hepatic decompensation compared with dipeptidyl peptidase 4 inhibitors (DPP4is) in a racially and ethnically diverse cohort of adults with Type 2 diabetes.
Inyoung Hwang, Yun Kim, Sang Won Lee
wiley +1 more source
Epigenetic mechanisms of retroviral regulation: a comparative review. [PDF]
Shin SY +3 more
europepmc +1 more source

